Key result
In patients with chronic hypertension, every 10% reduction in left atrial contractile function assessed by CMR was associated with a 1.75-fold increased hazard of major adverse cardiac events.
Why the study?
Does decreased left atrial contractile function assessed by CMR predict adverse cardiovascular outcomes in patients with chronic hypertension?
Cohort (n=210)
No
Does decreased left atrial contractile function assessed by CMR predict adverse cardiovascular outcomes in patients with chronic hypertension?
Effect estimate: HR 1.75 (95% CI 1.36-2.24)
p-value: p=<0.0001
Decreased left atrial contractile function assessed by CMR is a strong independent predictor of adverse cardiac events and mortality in patients with chronic hypertension.
Hypothesis-generating for CMR LA function in hypertensive risk stratification; prospective validation needed before clinical use.
BACKGROUND: Progressive left ventricular (LV) diastolic dysfunction due to hypertension (HTN) alters left atrial (LA) contractile function in a predictable manner. While increased LA size is a marker of LV diastolic dysfunction and has been shown to be predictive of adverse cardiovascular outcomes, the prognostic significance of altered LA contractile function is unknown. METHODS: A consecutive group of patients with chronic hypertension but without significant valvular disease or prior MI underwent clinically-indicated CMR for assessment of left ventricular (LV) function, myocardial ischemia, or viability. Calculation of LA volumes used in determining LA emptying functions was performed using the biplane area-length method. RESULTS: Two-hundred and ten patients were included in this study. During a median follow-up of 19 months, 48 patients experienced major adverse cardiac events (MACE), including 24 deaths. Decreased LA contractile function (LAEF(Contractile)) demonstrated strong unadjusted associations with patient mortality, non-fatal events, and all MACE. For every 10% reduction of LAEF(Contractile), unadjusted hazards to MACE, all-cause mortality, and non-fatal events increased by 1.8, 1.5, and 1.4-folds, respectively. In addition, preservation of the proportional contribution from LA contraction to total diastolic filling (Contractile/Total ratio) was strongly associated with lower MACE and patient mortality. By multivariable analyses, LAEF(Contractile) was the strongest predictor in each of the best overall models of MACE, all-cause mortality, and non-fatal events. Even after adjustment for age, gender, left atrial volume, and LVEF, LAEF(Contractile) maintained strong independent associations with MACE (p < 0.0004), all-cause mortality (p < 0.0004), and non-fatal events (p < 0.0004). CONCLUSIONS: In hypertensive patients at risk for left ventricular diastolic dysfunction, a decreased contribution of LA contractile function to ventricular filling during diastole is strongly predictive of adverse cardiac events and death.
No takes yet. Share an insight, caveat, or question.
Kaminski et al. (2011) conducted a cohort in Chronic hypertension (n=210). Left atrial contractile function (LAEF Contractile) assessment by CMR was evaluated on Major adverse cardiac events (MACE) (HR 1.75, 95% CI 1.36-2.24, p=<0.0001). In patients with chronic hypertension, every 10% reduction in left atrial contractile function assessed by CMR was associated with a 1.75-fold increased hazard of major adverse cardiac events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: